iifl-logo-icon 1

Metropolis Healthcare Ltd Half Yearly Results

1,648.4
(0.06%)
Feb 19, 2025|03:40:25 PM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Financials

Particulars (Rupees in Crores.)Sept-2024Mar-2024Sept-2023Mar-2023Sept-2022

Gross Sales

663.14

622.12

585.59

568

580.21

Excise Duty

0

0

0

0

0

Net Sales

663.14

622.12

585.59

568

580.21

Other Operating Income

0

0

0

0

0

Other Income

5.59

4.85

4.27

7.85

7.37

Total Income

668.73

626.96

589.86

575.85

587.58

Total Expenditure

494.45

477.29

447.84

427.23

432.69

PBIDT

174.28

149.67

142.02

148.63

154.9

Interest

9.44

10.88

11.66

12.28

14.52

PBDT

164.83

138.79

130.36

136.34

140.38

Depreciation

52.36

51.41

43.06

46.46

42.75

Minority Interest Before NP

0

0

0

0

0

Tax

28.89

23.97

25.63

22.01

26.68

Deferred Tax

-1.22

-0.4

-2.97

-1.48

-3.1

Reported Profit After Tax

84.81

63.82

64.64

69.35

74.04

Minority Interest After NP

0.34

0.25

0.39

0.2

0.31

Net Profit after Minority Interest

84.47

63.57

64.25

69.15

73.73

Extra-ordinary Items

0

0

0

0

0

Adjusted Profit After Extra-ordinary item

84.47

63.57

64.25

69.15

73.73

EPS (Unit Curr.)

6.92

12.41

12.55

13.5

11.39

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

0

0

0

Equity

10.25

10.25

10.24

10.24

10.23

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

26.28

24.05

24.25

26.16

26.69

PBDTM(%)

-

-

-

-

-

PATM(%)

12.78

10.25

11.03

12.2

12.76

Metropolis Healt: Related NEWS

Metropolis Healthcare Q3 Profit Rises 15.4% to ₹31.4 Crore
6 Feb 2025|10:11 AM

The EBITDA margin was stable at 22.3% and did not change much from the year-ago period.

Read More
Metropolis Acquires Core Diagnostics for ₹247 Crore to Boost Cancer Testing Expertise
10 Dec 2024|04:16 PM

This is a 100% stake purchase that will be funded through 55% cash and 45% equity swap. It expects completion in 60 days, after shareholders give their nod.

Read More
Top stocks for today - 11th November 2024
11 Nov 2024|12:08 PM

Here are some of the stocks that may see significant price movement today: Tata Motors, Asian Paints, Divi’s Laboratories, etc.

Read More
Top 10 stocks for today – 7th October 2024
7 Oct 2024|09:15 AM

Here are some of the stocks that may see significant price movement today: Titan Company, HDFC Bank, IndusInd Bank, etc.

Read More

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

plus
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.